Fennec Pharmaceuticals Inc. FRX.TO Stock
Fennec Pharmaceuticals Inc. Price Chart
Fennec Pharmaceuticals Inc. FRX.TO Financial and Trading Overview
| Fennec Pharmaceuticals Inc. stock price | 14.54 CAD |
| Previous Close | 12.05 CAD |
| Open | 12.05 CAD |
| Bid | 12.79 CAD x 0 |
| Ask | 12.88 CAD x 0 |
| Day's Range | 12.05 - 12.05 CAD |
| 52 Week Range | 7.25 - 14.41 CAD |
| Volume | 40 CAD |
| Avg. Volume | 260 CAD |
| Market Cap | 318.35M CAD |
| Beta (5Y Monthly) | 0.17007 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.82 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FRX.TO Valuation Measures
| Enterprise Value | 325.11M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 99.11425 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 101.216 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Fennec Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 0.17007 |
| 52-Week Change | 66.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.41 CAD |
| 52 Week Low | 7.25 CAD |
| 50-Day Moving Average | 10.87 CAD |
| 200-Day Moving Average | 11.65 CAD |
FRX.TO Share Statistics
| Avg. Volume (3 month) | 260 CAD |
| Avg. Daily Volume (10-Days) | 140 CAD |
| Shares Outstanding | 26.42M |
| Float | 16.96M |
| Short Ratio | 275.37 |
| % Held by Insiders | 17.28% |
| % Held by Institutions | 47.85% |
| Shares Short | 74.9K |
| Short % of Float | 0.41% |
| Short % of Shares Outstanding | 0.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -756.94% |
| Gross Margin | 94.36% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -74.17% |
| Return on Equity (ttm) | -1005.59% |
Income Statement
| Revenue (ttm) | 3.21M CAD |
| Revenue Per Share (ttm) | 0.12 CAD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.45M CAD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -26070000 CAD |
| Diluted EPS (ttm) | -1.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.39M CAD |
| Total Cash Per Share (mrq) | 0.7 CAD |
| Total Debt (mrq) | 25.14M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.389 |
| Book Value Per Share (mrq) | -0.278 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20779000 CAD |
| Levered Free Cash Flow (ttm) | -11332125 CAD |
Profile of Fennec Pharmaceuticals Inc.
| Country | Canada |
| State | NC |
| City | Research Triangle Park |
| Address | 68 TW Alexander Drive |
| ZIP | 27709 |
| Phone | 919 636 4530 |
| Website | https://www.fennecpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Q&A For Fennec Pharmaceuticals Inc. Stock
What is a current FRX.TO stock price?
Fennec Pharmaceuticals Inc. FRX.TO stock price today per share is 14.54 CAD.
How to purchase Fennec Pharmaceuticals Inc. stock?
You can buy FRX.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fennec Pharmaceuticals Inc.?
The stock symbol or ticker of Fennec Pharmaceuticals Inc. is FRX.TO.
Which industry does the Fennec Pharmaceuticals Inc. company belong to?
The Fennec Pharmaceuticals Inc. industry is Biotechnology.
How many shares does Fennec Pharmaceuticals Inc. have in circulation?
The max supply of Fennec Pharmaceuticals Inc. shares is 27.1M.
What is Fennec Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Fennec Pharmaceuticals Inc. PE Ratio is now.
What was Fennec Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Fennec Pharmaceuticals Inc. EPS is -0.82 CAD over the trailing 12 months.
Which sector does the Fennec Pharmaceuticals Inc. company belong to?
The Fennec Pharmaceuticals Inc. sector is Healthcare.